Compare Tempus AI (TEM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs State Street SPDR S&P Biotech ETF — how do they compare? Tempus AI trades at $49.06 (market cap $8.69B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| TEM | XBI | |
|---|---|---|
Market Cap | $8.69B | — |
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $103.25 | $164.28 |
52-Week Low | $42.37 | $85.16 |
Enterprise Value | $9.37B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
